Is the Cipla play Torrent Pharma’s cowboy moment?
The quiet, conservative Ahmedabad-based drug maker is ready to pledge family silver to acquire a rival many times its size. The question is whether it can survive its ambition.
26 September, 2023•12 min
0
26 September, 2023•12 min
0
More in Business
Business
NSE moves to settle colocation case with SEBI, sees sharp dip in profit
The stock exchange’s Q2 bottom line slipped on the back of a near Rs 1,300 crore provision to settle the long-pending case.
You may also like
Business
Laurus Labs is Indian pharma’s dark horse
With a promoter who is unafraid to make bold bets and pivot to businesses holding more promise, investors can only look forward to better times.
Business
Has Aurobindo Pharma left its wild swings behind?
The Hyderabad-based generics maker has seen its stock scale all-time highs and lows in quick succession. With big plans in place and regulatory heat easing, its roller-coaster days may be over.
Business
Is Mankind Indian pharma’s next big star?
From making condoms to steering clear of costly formulations, the drugmaker’s strategy of taking the road less travelled could now give it a seat at the high table.